Resources

Our latest news, blogs, reports, publications and upcoming events






























News, blogs, events, reports and more

Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.

Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.




Share
LinkedIn X Link



News
02 December 2019
LUNAC Therapeutics led project awarded £3.14 million under Innovate UK Biomedical Catalyst programme, to develop next-generation anticoagulant

LUNAC Therapeutics (LUNAC) along with the Medicines Discovery Catapult and the University of Leeds, has been awarded £3.14M funding.





News
29 November 2019
Medicines Discovery Catapult finalist for the Bionow Technical Service Award

Medicines Discovery Catapult recognised at the Bionow Annual Awards 2019, being a finalist for the Bionow Technical Service Award for their Pre-clinical Imaging service.


News
28 November 2019
Redx Pharma and Medicines Discovery Catapult awarded grant for biomarker project which aims to accelerate therapeutic development for idiopathic pulmonary fibrosis

Strategic collaboration will enable preclinical assessment and inform clinical development strategy for Redx’s Porcupine (RXC006) and ROCK2 inhibitors for fibrotic diseases with high unmet medical need.


Reports
23 October 2019
Use of health data by the life sciences industry: a UK perspective

Improving lives by enabling discoveries through health data


News
03 October 2019
A new initiative to revitalise drug discovery in psychiatric disease: the Psychiatry Consortium launches first call for proposals

Psychiatry Consortium announces its first call for projects that focus on the identification of novel drug targets to address the unmet therapeutic needs of people with mental health conditions.


Blogs
10 September 2019
The value of computational chemistry

Computational chemistry is the process of modeling chemistry in silico


Blogs
03 September 2019
What is Antiphospholipid Syndrome (APS)?

It is estimated to affect 1 in 2000 people






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



Medicines Discovery Catapult